logo transparent gif
top_white_spacer
Home Latest Stock Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Back
First   < Newer   1101-1120 of 10899   Older>   Last  
Latest Forum Topics / Biosensors  Post Reply
Is Biosensors a good buy?
bishan22
Elite
18-Dec-2012 10:59     
 
bishan22 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		OIR-2013-PICKS
 Useful To Me  Not Useful To Me
infancybird
Senior
18-Dec-2012 10:59     
 
infancybird About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Major acquisitions is happening in the 1H13. .....can  propel the price much higher,tgt 1.80...... thats what CS said. Now can accumulate piecemeal.

alexmay      ( Date: 18-Dec-2012 09:49) Posted:

bought some at 1.24.
 Useful To Me  Not Useful To Me


Bopanha
Master
18-Dec-2012 10:28     
 
Bopanha About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

Not a bad price.   I bought 1.14 sold 1.23 and bought again 1.24. Will wait to sell when it reaches my right price. Lol.

In the end my brokers was smiling broadly. But he also laughed because he bought too. Hahaha. 

Those who missed, better look for other counters because it may take some holding and staying power. Lol. 

alexmay      ( Date: 18-Dec-2012 09:49) Posted:

bought some at 1.24.
 Useful To Me  Not Useful To Me
WallStreet3
Member
18-Dec-2012 10:17     
 
WallStreet3 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

Not BUYING this stock for sure. Advertise too much. Like " Trap" . If readers follow the advice of some for this stock, just look at your opportunity costs. 

e.g. Yanlord

        TT Intl

      Ho Bee

      This forum only " real experts" :   TonyLim. 

 

 
 Useful To Me  Not Useful To Me
alexmay
Veteran
18-Dec-2012 09:49     
 
alexmay About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		bought some at 1.24.
 Useful To Me  Not Useful To Me


bishan22
Elite
18-Dec-2012 09:47     
 
bishan22 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Scoop some today. Good luck.  Smiley

yiming2000      ( Date: 18-Dec-2012 02:15) Posted:

Please scoop more, everybody. Keep scooping. Smiley 156
 Useful To Me  Not Useful To Me
yiming2000
Senior
18-Dec-2012 02:15     
 
yiming2000 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Please scoop more, everybody. Keep scooping. Smiley 156
 Useful To Me  Not Useful To Me
raykee
Senior
17-Dec-2012 18:48     
 
raykee About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		really hard to puah thru 1.3 sia....
 Useful To Me  Not Useful To Me


ricourean
Member
17-Dec-2012 17:07     
 
ricourean About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Volume done at  1.245 and 1.25  are actually higher than last friday. Accumulating clearly going on in anticipation for crossing barrier tomorrow or Wednesday.
 Useful To Me  Not Useful To Me
shinka2
Member
17-Dec-2012 15:37     
 
shinka2 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

Probably big block selling but actually not selling but collecting.

   

stockmarketmind      ( Date: 17-Dec-2012 10:28) Posted:

Most probably for the short term. At this price, maybe need a rest first.

infancybird      ( Date: 17-Dec-2012 10:23) Posted:

Noted big sales block at $1.25 by the i-seller of over million share for sales. Looks like we reach a limit here unless a huge buyer emerges.
 Useful To Me  Not Useful To Me
Splendid88
Member
17-Dec-2012 10:34     
 
Splendid88 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Stock should soar if break current resistance. Riding in excellent fundamentals!
 Useful To Me  Not Useful To Me
stockmarketmind
Master
17-Dec-2012 10:28     
 
stockmarketmind About Contact  Quote this Post!  
Yells: "stockmarketmindgames"
  x 0
  x 0

 Alert Admin 		Most probably for the short term. At this price, maybe need a rest first.

infancybird      ( Date: 17-Dec-2012 10:23) Posted:

Noted big sales block at $1.25 by the i-seller of over million share for sales. Looks like we reach a limit here unless a huge buyer emerges.

infancybird      ( Date: 13-Dec-2012 15:57) Posted:



This big i-seller is still out there but he seems to have about to exhaust his ammo( selling 100 lot at one go at time)  ....need to buy up all that he is planning to sell to break out of this tug of war. Glad to see greater and greater buy volume. 

 
 Useful To Me  Not Useful To Me


infancybird
Senior
17-Dec-2012 10:23     
 
infancybird About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Noted big sales block at $1.25 by the i-seller of over million share for sales. Looks like we reach a limit here unless a huge buyer emerges.

infancybird      ( Date: 13-Dec-2012 15:57) Posted:



This big i-seller is still out there but he seems to have about to exhaust his ammo( selling 100 lot at one go at time)  ....need to buy up all that he is planning to sell to break out of this tug of war. Glad to see greater and greater buy volume. 

 

raykee      ( Date: 12-Dec-2012 16:11) Posted:

Hai kana sold down again...
 Useful To Me  Not Useful To Me
skk888
Veteran
17-Dec-2012 09:45     
 
skk888 About Contact  Quote this Post! Style: Combined   Mood: peace
  x 0
  x 0

 Alert Admin 		hah just closed my position for profits..
contrary to your strategy, i'll re-enter when there's opportunity.. but this counter still has potentials for upside i believe..

bishan22      ( Date: 16-Dec-2012 13:07) Posted:

Will scoop more if it hits 1.25 and above.  Smiley 

skk888      ( Date: 10-Dec-2012 12:13) Posted:

Seems like its going to move.. Re entered again. :)
 Useful To Me  Not Useful To Me
ricourean
Member
17-Dec-2012 08:48     
 
ricourean About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		FTA agreement with EU to benefit pharmaceuticals. Will Biosensors stand to gain?
 Useful To Me  Not Useful To Me
bishan22
Elite
16-Dec-2012 13:07     
 
bishan22 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Will scoop more if it hits 1.25 and above.  Smiley 

skk888      ( Date: 10-Dec-2012 12:13) Posted:

Seems like its going to move.. Re entered again. :)
 Useful To Me  Not Useful To Me
starlene
Elite
14-Dec-2012 19:34     
 
starlene About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		This trading week from Mon 10 Dec to friday 14Dec we saw Biosensor trade between 1.14-1.25 not bad for it to close today at $1.24..still on the uptrend and it has since stopped its daily buybacks.So nest week by then all contra or those who cant hold should be out expect Biosensors to cross $1.30 easily

starlene      ( Date: 14-Dec-2012 16:14) Posted:

http://info.sgx.com/webcoranncatth.nsf/VwAttachments/Att_D0DEC4551894A10348257AD3004DD6DC/$file/Biosensors_announces_first_patient_enrolled_in_LEADERS_FREE.pdf?openelement



ricourean      ( Date: 14-Dec-2012 12:28) Posted:

Singapore Business Review:

Biosensors International up for a 2013 growth spurt



Chinese market advantage will be the key enabler.

Here's more from Maybank Kim Eng:

The old, old story. The fundamental growth story of Biosensors has not changed - a clinically proven BioMatrixTM drug-eluting stent (DES) threatening to steal market shares from established medical device companies, with a next generation stent (BioFreedomTM) in the pipeline. Despite growing penetration, concerns on future price cuts have taken precedence this year. This overhang has not been totally removed, but we see pockets of growth potential that will spark a revival in 2013.

An edge in the China market. There is a strong China element in Biosensors, evident in its shareholding structure and geographical revenue contribution, with JWMS accounting for about a third of total revenue. In our view, Biosensors has an edge in the Chinese market. The SFDA approval for BioMatrixTM has been taking longer than expected, but our recent conversation with the company suggests that Biosensors is now focusing on bringing on Excel II (improved version of Excel Stent) and its next generation product BioFreedomTM to penetrate the Chinese market instead.

M& A activities in the pipeline? Biosensors has professed its intention to morph into a multi-product medical devices company. While it has strong efforts in R& D, the faster way would be through M& A, and it could do so given a strong balance sheet (net cash of USD332m as at 2QFY3/13). We understand that Biosensors is actively looking at such opportunities and have conducted due diligence on certain companies. It also shared that the US is a market it is keen to get into. We think that there is a high chance of seeing some corporate actions in 2013.

More aggressive marketing in Japan. Lower licensing revenue was a drag on 2QFY3/13 results. Terumo is bent on stepping up marketing
efforts to regain Nobori’s market share, with Biosensors also setting up offices in Japan to help. In our view, the new licensing agreement
favours Biosensors over Terumo with a guaranteed minimum flat fee. I’ll take if you don’t, Reiterate BUY. On 8 Nov 2012, Biosensors initiated its first ever share buybacks since listing. 19.8m shares were repurchased over 17 trading days at SGD1.08-1.17 per share, demonstrating its confidence
 Useful To Me  Not Useful To Me
starlene
Elite
14-Dec-2012 16:14     
 
starlene About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		http://info.sgx.com/webcoranncatth.nsf/VwAttachments/Att_D0DEC4551894A10348257AD3004DD6DC/$file/Biosensors_announces_first_patient_enrolled_in_LEADERS_FREE.pdf?openelement



ricourean      ( Date: 14-Dec-2012 12:28) Posted:

Singapore Business Review:

Biosensors International up for a 2013 growth spurt



Chinese market advantage will be the key enabler.

Here's more from Maybank Kim Eng:

The old, old story. The fundamental growth story of Biosensors has not changed - a clinically proven BioMatrixTM drug-eluting stent (DES) threatening to steal market shares from established medical device companies, with a next generation stent (BioFreedomTM) in the pipeline. Despite growing penetration, concerns on future price cuts have taken precedence this year. This overhang has not been totally removed, but we see pockets of growth potential that will spark a revival in 2013.

An edge in the China market. There is a strong China element in Biosensors, evident in its shareholding structure and geographical revenue contribution, with JWMS accounting for about a third of total revenue. In our view, Biosensors has an edge in the Chinese market. The SFDA approval for BioMatrixTM has been taking longer than expected, but our recent conversation with the company suggests that Biosensors is now focusing on bringing on Excel II (improved version of Excel Stent) and its next generation product BioFreedomTM to penetrate the Chinese market instead.

M& A activities in the pipeline? Biosensors has professed its intention to morph into a multi-product medical devices company. While it has strong efforts in R& D, the faster way would be through M& A, and it could do so given a strong balance sheet (net cash of USD332m as at 2QFY3/13). We understand that Biosensors is actively looking at such opportunities and have conducted due diligence on certain companies. It also shared that the US is a market it is keen to get into. We think that there is a high chance of seeing some corporate actions in 2013.

More aggressive marketing in Japan. Lower licensing revenue was a drag on 2QFY3/13 results. Terumo is bent on stepping up marketing
efforts to regain Nobori’s market share, with Biosensors also setting up offices in Japan to help. In our view, the new licensing agreement
favours Biosensors over Terumo with a guaranteed minimum flat fee. I’ll take if you don’t, Reiterate BUY. On 8 Nov 2012, Biosensors initiated its first ever share buybacks since listing. 19.8m shares were repurchased over 17 trading days at SGD1.08-1.17 per share, demonstrating its confidence
 Useful To Me  Not Useful To Me
raykee
Senior
14-Dec-2012 12:36     
 
raykee About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		the direction seems wrong....
 Useful To Me  Not Useful To Me
ricourean
Member
14-Dec-2012 12:28     
 
ricourean About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

Singapore Business Review:

Biosensors International up for a 2013 growth spurt



Chinese market advantage will be the key enabler.

Here's more from Maybank Kim Eng:

The old, old story. The fundamental growth story of Biosensors has not changed - a clinically proven BioMatrixTM drug-eluting stent (DES) threatening to steal market shares from established medical device companies, with a next generation stent (BioFreedomTM) in the pipeline. Despite growing penetration, concerns on future price cuts have taken precedence this year. This overhang has not been totally removed, but we see pockets of growth potential that will spark a revival in 2013.

An edge in the China market. There is a strong China element in Biosensors, evident in its shareholding structure and geographical revenue contribution, with JWMS accounting for about a third of total revenue. In our view, Biosensors has an edge in the Chinese market. The SFDA approval for BioMatrixTM has been taking longer than expected, but our recent conversation with the company suggests that Biosensors is now focusing on bringing on Excel II (improved version of Excel Stent) and its next generation product BioFreedomTM to penetrate the Chinese market instead.

M& A activities in the pipeline? Biosensors has professed its intention to morph into a multi-product medical devices company. While it has strong efforts in R& D, the faster way would be through M& A, and it could do so given a strong balance sheet (net cash of USD332m as at 2QFY3/13). We understand that Biosensors is actively looking at such opportunities and have conducted due diligence on certain companies. It also shared that the US is a market it is keen to get into. We think that there is a high chance of seeing some corporate actions in 2013.

More aggressive marketing in Japan. Lower licensing revenue was a drag on 2QFY3/13 results. Terumo is bent on stepping up marketing
efforts to regain Nobori’s market share, with Biosensors also setting up offices in Japan to help. In our view, the new licensing agreement
favours Biosensors over Terumo with a guaranteed minimum flat fee. I’ll take if you don’t, Reiterate BUY. On 8 Nov 2012, Biosensors initiated its first ever share buybacks since listing. 19.8m shares were repurchased over 17 trading days at SGD1.08-1.17 per share, demonstrating its confidence

 Useful To Me  Not Useful To Me
                                                         First   < Newer   1101-1120 of 10899   Older>   Last  



ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.